Related Experiment Videos
Allopurinol influences aminophenazone elimination.
1Department of Pharmacology and Therapeutics, Trinity College Medical School, St James's Hospital, Dublin, Ireland.
Clinical Pharmacokinetics
|August 1, 1990
Summary
Allopurinol may interact with other drugs by affecting liver metabolism. This study found allopurinol prolonged the half-life of aminopyrine, suggesting potential for drug interactions.
Area of Science:
- Pharmacology
- Hepatology
- Drug Metabolism
Background:
- Allopurinol is commonly prescribed for hyperuricemia.
- Potential drug interactions involving allopurinol require further investigation.
- Hepatic oxidative metabolism plays a crucial role in drug clearance.
Observation:
- An interaction between allopurinol and theophylline/warfarin was noted in two patients.
- A [14C]-aminophenazone (aminopyrine) breath test was employed to assess hepatic oxidative metabolism.
- The test was conducted before and during daily allopurinol treatment in five hyperuricemia patients.
Findings:
- Allopurinol significantly prolonged the [14CO2]-aminophenazone half-life (from 72 ± 13 to 104 ± 16 minutes, p < 0.05).
- This indicates that allopurinol inhibits hepatic oxidative metabolism.
- The effect on aminopyrine metabolism suggests a broader impact beyond xanthine oxidase inhibition.
Implications:
- Allopurinol may cause clinically significant drug interactions.
- The inhibitory effect on oxidative metabolism could affect the clearance of other drugs.
- Clinicians should consider potential interactions when prescribing allopurinol concurrently with other medications.